This treatment led to increased overexpression of insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), a carcinoembryonic protein that is overexpressed in many tumors such as malignant gliomas. Here, IGF2BP3 is linked to malignant glioma.